Compare State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF (FLRN) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF vs Moderna, Inc. — how do they compare? State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.77, while Moderna, Inc. trades at $60.73 (market cap $24.18B). Which is the better fit depends on your goals.
| FLRN | MRNA | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $30.86 | $81.80 |
52-Week Low | $30.65 | $22.36 |
Market Cap | — | $24.18B |
Enterprise Value | — | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF
FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
